Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights
- 1 July 2023
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 84 (1), 127-137
- https://doi.org/10.1016/j.eururo.2023.04.020
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Genetic Variant as a Selection Marker for Anti–Prostate Stem Cell Antigen Immunotherapy of Bladder CancerJNCI Journal of the National Cancer Institute, 2012
- Common genetic variants in the PSCA gene influence gene expression and bladder cancer riskProceedings of the National Academy of Sciences of the United States of America, 2012
- Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancerHuman Molecular Genetics, 2012
- A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3Human Molecular Genetics, 2011
- European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility geneHuman Molecular Genetics, 2011
- A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European backgroundPharmacogenetics and Genomics, 2011
- A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility lociNature Genetics, 2010
- A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancerNature Genetics, 2010
- Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancerNature Genetics, 2009
- Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplificationOncogene, 2007